Prolactin Promotes Hepatocellular Carcinoma through Janus Kinase 2

A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells

(2015) Li Lin et al.   NEOPLASIA

Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

(2011) S. Eguchi et al.   BRITISH JOURNAL OF SURGERY

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case–control study from Poland

(2010) J M Faupel-Badger et al.   BRITISH JOURNAL OF CANCER

Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms

(2010) Wei Yue et al.   INTERNATIONAL JOURNAL OF CANCER

Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer

(2010) K Sakamoto et al.   ONCOGENE

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

(2010) V. Rouet et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells

(2009) R. Behera et al.   CARCINOGENESIS

Nuclear cyclin D1: An oncogenic driver in human cancer

(2009) Jong Kyong Kim et al.   JOURNAL OF CELLULAR PHYSIOLOGY

New mechanisms for PRLr action in breast cancer

(2009) Charles V. Clevenger et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

(2008) Philip W. Harvey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Will GnRH antagonists improve prostate cancer treatment?

(2008) Ilpo Huhtaniemi et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The Lifetime Cost of Hepatocellular Carcinoma

(2008) Hui-Chu Lang et al.   Applied Health Economics and Health Policy